Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

BACKGROUND: Statins have been proved to be effective in reduction of mortality and morbidity when started in the early secondary prevention in stabilized patients after acute coronary syndrome (ACS). The safety and efficacy of statin administration directly in the first-line therapy in unstable ACS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ostadal, Petr, Alan, David, Vejvoda, Jiri, Kukacka, Jiri, Macek, Milan, Hajek, Petr, Mates, Martin, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Holm, Frantisek, Telekes, Peter, Horak, David, Blasko, Peter, Zemanek, David, Veselka, Josef, Cepova, Jana
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886041/
https://ncbi.nlm.nih.gov/pubmed/20500832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-61
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi